Related Experiment Videos
Purulent pleurisy caused by Campylobacter lari
Summary
A rare case of purulent pleurisy caused by Campylobacter lari in an elderly patient was successfully treated with antibiotics and surgical drainage. The Campylobacter lari isolate showed sensitivity to several key antibiotics, guiding effective treatment.
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Background:
- Campylobacter species are known human pathogens, typically causing gastrointestinal illness.
- Pleurisy, an inflammation of the lung lining, can arise from various infections.
- Campylobacter lari is a less common cause of invasive infections in humans.
Observation:
- An 80-year-old, debilitated patient presented with purulent pleurisy.
- The causative agent was identified as a Campylobacter lari isolate.
- The patient's condition necessitated surgical drainage and antibiotic treatment.
Findings:
- The Campylobacter lari isolate exhibited full sensitivity to clarithromycin, tetracycline, aminoglycosides, and ciprofloxacin.
- Amoxicillin/clavulanic acid and ofloxacin were used for antibiotic therapy.
- Imipenem and amoxicillin/clavulanic acid demonstrated the highest activity among tested beta-lactam agents.
Implications:
- This case highlights Campylobacter lari as a potential cause of severe respiratory infections, such as pleurisy.
- Understanding antibiotic susceptibility patterns is crucial for managing invasive Campylobacter infections.
- Prompt diagnosis and appropriate antimicrobial therapy, alongside surgical intervention when needed, are vital for patient outcomes.